Αποτελέσματα Αναζήτησης
20 Νοε 2020 · Since the original clinical description of HCM >60 years ago, various names have been used to describe this disease, including idiopathic hypertrophic subaortic stenosis and hypertrophic obstructive cardiomyopathy.
- View Epub
PK ‹#¾Xoa«, mimetypeapplication/epub+zipPK ‹#¾X...
- Pdf/Epub
PK ‹#¾Xoa«, mimetypeapplication/epub+zipPK ‹#¾X...
- 2018 Acc/Aha/Hrs Guideline on The Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay
Hypertrophic cardiomyopathy: ACC/AHA: 2011 S1.4-13...
- Cardiovascular Imaging
Hypertrophic cardiomyopathy (HCM) is an inherited...
- Cardiovascular Genetics
Background—Yield of causative variants in hypertrophic...
- Genomic and Precision Medicine
Hypertrophic cardiomyopathy (HCM) is an inherited...
- Abnormal Blood Pressure Response During Exercise in Hypertrophic Cardiomyopathy
To investigate the incidence of abnormal exercise blood...
- Executive Summary
These practice guidelines represent a consensus of expert...
- View Epub
The 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy (AHA/ACC/Multisociety HCM Guideline) provides guidance for clinicians on the management of patients with hypertrophic cardiomyopathy (HCM). 1 The guideline contains updated, evidence-based recommendations that build on those from the 2020 HCM ...
20 Νοε 2020 · This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting documentation to encourage their use.
20 Νοε 2020 · For symptomatic patients without provoked gradients, an exercise echocardiogram should be performed. For clinically stable HCM patients, surveillance echocardiograms should be considered every 1-2 years to assess for changes in extent of hypertrophy, obstruction, and cardiac function.
Hypertrophic cardiomyopathy remains a common genetic heart disease reported in populations globally. Recommendations from the “2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy” have been updated with new evidence to guide clinicians.
Clinical practice guidelines provide recommendations applicable to patients with or at risk of developing car-diovascular disease. The focus is on medical practice in the United States, but these guidelines are relevant to patients throughout the world. Although guidelines may be used to inform regulatory or payer decisions, the in-
22 Δεκ 2020 · 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020 Dec 22;142 (25):e558-e631. doi: 10.1161/CIR.0000000000000937. Epub 2020 Nov 20.
